A Collaborative Approach to Supporting Biosimilar use in Community Pharmacy

This program assists pharmacists in helping patients taking biologics and biosimilars.




Pharmacists play a key role on the team of individuals supporting patients taking biologics and biosimilars. This involves building relationships with both their patients as well as other healthcare providers involved in their care. This complimentary, expert-reviewed, three-module course covers steps that you can take to help empower your patients.

Pharmacist Carolyn Whiskin provides an overview of the current biosimilars landscape using a national lens. Then, Carolyn and gastroenterologist, Dr. John Marshall, have a dialogue to discuss switching, multiple biosimilar products, patient support programs, the nocebo effect, and other common considerations. Finally, a person living with Crohn’s disease shares her own experience using an injectable biologic drug.

This program was created by Pear Healthcare Inc under an educational grant from Amgen.


Learning objectives:

Upon completion of this course, participants will be able to:

  • Recall the definition of biosimilars and their uses.
  • Explain the rationale for non-interchangeability between biosimilars and reference biologics or other biosimilar products.
  • Discuss considerations for non-medical switching.
  • Review storage and inventory management considerations for biosimilars.
  • Describe unique patient education opportunities regarding use of biosimilars.

Course outline:

The course has one video containing 3 modules

Course at a glance:

  • 1 Hour to complete
  • 1 CEU
  • Available until May 10, 2022
  • Online

Who should take this course:


Development Team:

  • Rosemary Patodia
  • Carolyn Whiskin, RPh, BScPhm, NCMP
  • Dr. John Marshall